StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Check out SEDI boys and girls

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Jan 26, 2023 10:05am

321 Views

Post# 35247563

RE:RE:Check out SEDI boys and girls

The company extends $6 million in warrants varrying in exercise price from $0.48 to $1.53. Now they grant options to directors at a price of 0.065.

It's almost like the company feels the share price will increase from here. Now why would that be?

Nailbiter2 wrote:

Filed 2023-01-25 23:44

Tx date 2023-01-24 $SZLS
StageZero Life Sciences Ltd. Riggs, Rory
4 - Director of Issuer

Direct Ownership

Options
50 - Grant of options $49,725
+765,000 vol
.065 each 1,569,117

Filed 2023-01-25 23:32

Tx date 2023-01-24 $SZLS
StageZero Life Sciences Ltd. MacRae, Garth A. C.
4 - Director of Issuer

Direct Ownership

Options
50 - Grant of options $49,725
+765,000 vol
.065 each 1,051,120

Filed 2023-01-25 23:29

Tx date 2023-01-24 $SZLS
StageZero Life Sciences Ltd. Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer

Direct Ownership

Options
50 - Grant of options $91,455
+1,407,000 vol
.065 each 3,818,250

Filed 2023-01-25 23:27

Tx date 2023-01-24 $SZLS
StageZero Life Sciences Ltd. Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer

Direct Ownership

Options
50 - Grant of options $49,725
+765,000 vol
.065 each 2,411,250

Filed 2023-01-25 23:22

Tx date 2023-01-24 $SZLS
StageZero Life Sciences Ltd. Glorikian, Harry
4 - Director of Issuer

Direct Ownership

Options
50 - Grant of options $49,725
+765,000 vol
.065 each 1,076,120

Older filings

Nailbiter2 wrote:

Filed 2023-01-25 23:44 Tx date 2023-01-24	$SZLS StageZero Life Sciences Ltd.	Riggs, Rory 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$49,725 +765,000 vol .065 each	1,569,117
Filed 2023-01-25 23:32 Tx date 2023-01-24	$SZLS StageZero Life Sciences Ltd.	MacRae, Garth A. C. 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$49,725 +765,000 vol .065 each	1,051,120
Filed 2023-01-25 23:29 Tx date 2023-01-24	$SZLS StageZero Life Sciences Ltd.	Howard-Tripp, James 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$91,455 +1,407,000 vol .065 each	3,818,250
Filed 2023-01-25 23:27 Tx date 2023-01-24	$SZLS StageZero Life Sciences Ltd.	Howard-Tripp, James 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$49,725 +765,000 vol .065 each	2,411,250
Filed 2023-01-25 23:22 Tx date 2023-01-24	$SZLS StageZero Life Sciences Ltd.	Glorikian, Harry 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$49,725 +765,000 vol .065 each	1,076,120
Older filings